What is the maximum recommended norepinephrine infusion dose in micrograms per kilogram per day?

Maximum Norepinephrine Infusion Dose

There is no absolute maximum dose for norepinephrine, but the FDA label documents that doses as high as 68 mg/day (approximately 47 mcg/min in a 70 kg patient, or 0.67 mcg/kg/min) have been used when patients remain hypotensive, though occult blood volume depletion must always be suspected and corrected. 1

Standard Dosing Framework

The typical starting dose is 0.1-0.5 mcg/kg/min with titration to achieve a mean arterial pressure (MAP) of ≥65 mmHg 2. The average maintenance dose ranges from 2-4 mcg/min (approximately 0.03-0.06 mcg/kg/min in a 70 kg adult) 1.

High-Dose Considerations

When converting to daily dosing as requested:

• Standard maintenance: 2-4 mcg/min = 2,880-5,760 mcg/day (approximately 40-80 mcg/kg/day in a 70 kg patient)
• High documented dose: 68 mg/day = 68,000 mcg/day (approximately 970 mcg/kg/day in a 70 kg patient) 1

Clinical Context for High Doses

Before escalating beyond 0.5-1.0 mcg/kg/min, you must aggressively rule out and correct hypovolemia. The FDA label explicitly states that when enormous doses are required, occult blood volume depletion should always be suspected 1. Central venous pressure monitoring is recommended to detect and treat this situation 1.

Recent research suggests important thresholds:

• Doses >0.4 mcg/kg/min are associated with significantly increased mortality (hazard ratio 7.5) 3
• Doses >1.13 mcg/kg/min predict early ICU mortality with 67% sensitivity and 80% specificity 4
• High-dose norepinephrine (≥0.6 mcg/kg/min) is independently associated with higher organ dysfunction scores 5

Practical Dosing Algorithm

1. Start at 0.1-0.5 mcg/kg/min and titrate to MAP ≥65 mmHg 2

2. If requiring >0.5 mcg/kg/min:

   • Reassess volume status aggressively
   • Consider adding vasopressin (0.03 units/min) or epinephrine rather than escalating norepinephrine alone 6
   • Ensure central venous access 1

3. If requiring >1.0 mcg/kg/min:

   • This represents refractory shock
   • Strongly consider adding second-line vasopressors (vasopressin up to 0.03 units/min or epinephrine) 6
   • Reassess for correctable causes (ongoing bleeding, adrenal insufficiency, cardiac dysfunction)

4. Doses >1.13 mcg/kg/min are associated with poor prognosis and should prompt consideration of goals of care discussions 4

Important Caveats

There is tremendous variability in practice. A 2024 international survey found protocolized maximum doses ranging from 20-400 mcg/min (non-weight-based) and 0.2-10 mcg/kg/min (weight-based), with median values of 30 mcg/min and 1 mcg/kg/min respectively 7. Only 19% of institutions reported using dose caps 7.

The risk of tissue ischemia increases with dose and duration. Prolonged infusions at high doses are associated with increased pressure injury risk, particularly when cumulative duration exceeds 2 days at doses >0.20 mcg/kg/min 8.

Pediatric dosing differs: In children, the range is typically 0.1-1.0 mcg/kg/min, with doses as high as 5 mcg/kg/min sometimes necessary 9.

Key Safety Measures

• Always use central venous access when possible to minimize extravasation risk 2, 1
• Have phentolamine available (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL saline) for infiltration into extravasation sites 9
• Monitor for end-organ perfusion rather than relying solely on MAP targets, as microcirculatory dysfunction may occur despite adequate blood pressure 10